Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Leukapheresis Market from 2024 to 2025?

There has been robust growth in the leukapheresis market size in the past few years. The market size is projected to expand from $66.80 billion in 2024 to $72.23 billion in 2025, with a compound annual growth rate (CAGR) of 8.1%. The surge in the historical period can be credited to the escalating prevalence of leukemia and autoimmune diseases, the heightened demand for personalized medicine, enhancements in stem cell research, advancements in apheresis technologies, the expansion of clinical trial activities, and an increased understanding of immunotherapy applications.

What Is the Projected Market Size of the Leukapheresis Market?

The future of the leukapheresis market looks promising with strong growth predicted in the coming years. It’s projected to reach $97.83 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.9%. The anticipated growth during the forecasted period is due to several factors including a surge in demand for customized cell treatments, an increase in clinical trials focusing on immuno-oncology, a rising trend towards regenerative medicine, expansion in biopharmaceutical production, improved reimbursement practices, and a broader understanding of cell-based research and therapies. Major anticipated trends for the forecasted period encompass advancements in cell separation technologies, the use of AI to optimize procedures, the innovation of mobile leukapheresis devices, progress in gene and cell therapy, enhanced methods for donor screening, and a shift towards cloud-based systems for data tracking.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24277&type=smp

Who are the Major Competitors in the Leukapheresis Market Outlook?

Major companies operating in the leukapheresis market are Fresenius Kabi, Grifols S.A., Terumo BCT Inc., Nikkiso Co., STEMCELL Technologies Inc., Haemonetics Corporation, Macopharma, Discovery Life Sciences, BioIVT LLC, StemExpress LLC, MEDICA S.p.A, AllCells LLC, Caltag Medsystems Ltd., Miltenyi Biotec, Immune Therapy Holdings AB, Cellsep Laboratories, Accegen Biotec, Key Biologics LLC, HemaCare Corporation, Puriblood Medical, Cytopheron Technologies, Adacyte Therapeutics.

What Is Fueling Growth in the Leukapheresis Market?

The leukapheresis market is anticipated to expand due to the increasing prevalence of autoimmune diseases. These diseases are characterized by the body’s immune system mistakenly targeting its own healthy tissue. Modern environmental factors and decreased exposure to microbes during early life disrupt the immune balance, leading to a rise in autoimmune disorders. Leukapheresis is used to treat these diseases by specifically targeting and removing the harmful white blood cells responsible for the immune system’s onslaught on the body’s tissues. In line with this, Versorgungsatlas.de, a German organization, reported that in 2022, out of 73,241,305 insured people, 6,304,340 were diagnosed with at least one autoimmune disease. This accounted for a raw prevalence rate of 8.61% in November 2024. Hence, the increasing occurrence of autoimmune diseases is fuelling the growth of the leukapheresis market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24277&type=smp

Which Leukapheresis Market Segments Are Growing the Fastest?

The leukapheresis market covered in this report is segmented –

1) By Type: Granulocyte Apheresis, Lymphocyte Apheresis, Monocyte Apheresis

2) By Product: Leukapheresis Devices, Centrifugal Devices, Membrane Separators, Leukapheresis Disposables

3) By Application: Research Application, Cancer Research, Immunology Research, Therapeutics Application, Hematologic Disorders, Autoimmune Diseases, Other Applications

4) By End User: Blood Component Providers And Blood Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Transfusion Centers

Subsegments:

1) By Granulocyte Apheresis: Neutrophil Apheresis, Eosinophil Apheresis, Basophil Apheresis

2) By Lymphocyte Apheresis: T-Cell Apheresis, B-Cell Apheresis, Natural Killer (NK) Cell Apheresis

3) By Monocyte Apheresis: Classical Monocytes, Non-Classical Monocytes, Intermediate Monocytes

Which Industry Trends Are Shaping the Future of the Leukapheresis Market?

Leading businesses in the leukapheresis market are enhancing the quality and efficiency of cell therapy manufacturing by focusing on innovations such as GMP-grade leukopaks. These leukopaks, derived from leukapheresis, are processed under strict good manufacturing practice (GMP) standards, leading to high viability and functionality of the cells collected for therapeutic applications. For instance, in November 2024, Sanguine Biosciences, a biotechnology company based in the USA, introduced LeukoCert, a GMP-grade leukopak designed to expedite workflows and speed up the development of cell therapy. Made in accordance to rigorous GMP standards, LeukoCert provides high-quality starting materials accessible in fresh whole or half packs, enabling researchers to progress their studies and bring new cell therapies to the market more quickly.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/leukapheresis-global-market-report

Which Countries Are Leading the Leukapheresis Market?

North America was the largest region in the leukapheresis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the leukapheresis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/customise?id=24277&type=smp

This Report Delivers Insight On:

1. How big is the leukapheresis market, and how is it changing globally?

2. Who are the major companies in the leukapheresis market, and how are they performing?

3. What are the key opportunities and risks in the leukapheresis market right now?

4. Which products or customer segments are growing the most in the leukapheresis market?

5. What factors are helping or slowing down the growth of the leukapheresis market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model